Sunday	(May 9, 1999) Panel Discussions
	Session I: ‘How to Select a Reference Lab’
	Joseph Waner, Children’s Hospital of Oklahoma, Oklahoma City OK
	Danny Wiedbrauk, William Beaumont Hospital, Royal Oak MI
	Angela Caliendo, Massachusetts General Hospital, Boston MA
	Karen Carroll, University of Utah, Salt Lake City UT
	Wayne Hogrefe, MRL Pharmaceuticals, Cypress CA
	Session II: ‘Improving Specimen Quality’
	James Mahony, St. Joseph’s Hospital, Hamilton, Ontario, Canada
Day 1	(May 10, 1999) Session I — Clinical Aspects of Viral Diseases
	‘TTV—A Virus Searching for Disease’
	Prof. Yvonne Cossart, University of Sydney NSW, Australia
	‘Nutrition and Viral Disease’
	Melinda Beck, University of North Carolina, Chapel Hill NC
	‘Adenovirus Disease in the Immunocompromised Host’
	Christine Robinson, Denver Children’s Hospital, Denver CO
	‘Is Viral Disease Influenced by El Niño? The Hantavirus Model’
	Stephen A. Young, The University of New Mexico, Albuquerque NM
Day 2	(May 11, 1999) Session II – Laboratory Diagnosis of Viral Infections
	‘Testing for Proficiency and Competence in the Viral Diagnostic Laboratory’
	Ann Warford, Stanford University Hospital, Stanford CA
	‘Positioning Your Laboratory to Adapt to Modern Health Care’
	Jan Steiner, Chi Laboratory Systems, Ann Arbor MI
	‘Clinical Utility of Laboratory Methods for Detection of CNS Viral Infections’
	Gregory Storch, St. Louis Children’s Hospital, St. Louis MO
	‘Automation of Diagnostic Virology’
	Curt A. Gleaves, Providence Portland Medical Center, Portland OR
	Phil Hanff Memorial Clinical Case: Presentations and Discussion
	Marie L. Landry, Yale University School of Medicine, New Haven CT
	C. George Ray, St. Louis University Medical Center, St. Louis MO
Day 3	(May 12, 1999) Session III – Prevention of and Therapy for Viral Infections
	‘Antivirals for Enterovirus Infections’
	Daniel J. Pevear, Viropharma Inc., Exton PA
	‘Anti-neuraminidase Treatment for Influenza’
	Fred Hayden, University of Virginia Health Sciences Center, Charlottesville VA
	‘Antivirals for the Treatment of Hepatitis B and Hepatitis C’
	Christopher O’Brien, University of Miami School of Medicine, Miami FL
	‘Nucleic Acid-based Anti-viral Approaches to HCV Infection’
	Jack R. Wands, MGH Cancer Center, Charlestown MA